Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Osteoporos Int ; 17(7): 1008-12, 2006.
Article in English | MEDLINE | ID: mdl-16758139

ABSTRACT

INTRODUCTION: Pregnancy and lactation-associated osteoporosis (PLO) is an uncommon condition characterized by the occurrence of fracture(s) during late pregnancy or the puerperium. The aetiology is uncertain, and its management and natural history poorly defined. METHODS: We report a series of 11 women with PLO seen at our institution over the past 20 years, with follow-up ranging from 1 to 19 years. RESULTS: Ten women presented with painful low-trauma vertebral fractures, at a median of 1 month postpartum. In nine cases the fractures were multiple (median: 3, range: 2-5). At least one recognised risk factor for osteoporosis (low body weight, smoking history, family history of osteoporosis/fracture, vitamin D insufficiency) was present in nine patients. Bone density was in the osteoporotic range at the spine (mean T score: -2.8), with less marked reduction at the proximal femur (mean T score: -1.9). Nine patients received bisphosphonate treatment, for a median duration of 24 months. In the five women who received a bisphosphonate within 1 year of presentation, spinal bone density increased by 23% over baseline values after 2 years of treatment (p=0.0014). Of the 5 women who had subsequent pregnancies, one, who had declined bisphosphonate therapy after the initial presentation, sustained a fracture in the postpartum period. Two patients (both of whom were followed for at least 10 years) sustained fractures outside of pregnancy. CONCLUSIONS: PLO is therefore associated with significant morbidity, a high prevalence of recognized risk factors for osteoporosis and a risk of recurrence in subsequent pregnancies. Bisphosphonate therapy administered soon after presentation substantially increases spinal bone density in patients with PLO.


Subject(s)
Diphosphonates/therapeutic use , Lactation , Osteoporosis/drug therapy , Pregnancy Complications/drug therapy , Adult , Bone Density , Female , Humans , Osteoporosis/etiology , Pregnancy , Spinal Fractures/etiology
2.
Int J Food Sci Nutr ; 55(3): 171-8, 2004 May.
Article in English | MEDLINE | ID: mdl-15223592

ABSTRACT

Nuts are high in fat but have a fatty acid profile that may be beneficial in relation to risk of coronary heart disease. Nuts also contain other potentially cardioprotective constituents including phytosterols, tocopherols and squalene. In the present study, the total oil content, peroxide value, composition of fatty acids, tocopherols, phytosterols and squalene content were determined in the oil extracted from freshly ground walnuts, almonds, peanuts, hazelnuts and the macadamia nut. The total oil content of the nuts ranged from 37.9 to 59.2%, while the peroxide values ranged from 0.19 to 0.43 meq O2/kg oil. The main monounsaturated fatty acid was oleic acid (C18:1) with substantial levels of palmitoleic acid (C16:1) present in the macadamia nut. The main polyunsaturated fatty acids present were linoleic acid (C18:2) and linolenic acid (C18:3). alpha-Tocopherol was the most prevalent tocopherol except in walnuts. The levels of squalene detected ranged from 9.4 to 186.4 microg/g. beta-Sitosterol was the most abundant sterol, ranging in concentration from 991.2 to 2071.7 microg/g oil. Campesterol and stigmasterol were also present in significant concentrations. Our data indicate that all five nuts are a good source of monounsaturated fatty acid, tocopherols, squalene and phytosterols.


Subject(s)
Dietary Fats, Unsaturated/analysis , Fatty Acids/analysis , Nuts/chemistry , Arachis/chemistry , Chromatography, High Pressure Liquid/methods , Corylus/chemistry , Food Analysis/methods , Humans , Juglans/chemistry , Macadamia/chemistry , Phytosterols/analysis , Prunus/chemistry , Squalene/analysis , Tocopherols/analysis
3.
J Endod ; 27(11): 703-5, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11716086

ABSTRACT

This case report demonstrates Mineral Trioxide Aggregate obturation of the root canal system of a retained primary mandibular second molar where no succedaneous permanent tooth was present. The technique seemed to provide a biocompatible seal of the root canal system in this case. It is not recommended for obturation of primary teeth that are expected to exfoliate since it is anticipated that Mineral Trioxide Aggregate would be absorbed slowly, if at all.


Subject(s)
Aluminum Compounds/therapeutic use , Calcium Compounds/therapeutic use , Molar , Oxides/therapeutic use , Root Canal Filling Materials/therapeutic use , Root Canal Obturation , Silicates/therapeutic use , Tooth, Deciduous , Adult , Biocompatible Materials/therapeutic use , Chronic Disease , Dental Amalgam , Dental Caries/therapy , Dental Pulp Necrosis/therapy , Dental Restoration Failure , Drug Combinations , Follow-Up Studies , Humans , Male , Mandible , Periapical Abscess/therapy , Periapical Periodontitis/therapy
4.
FEMS Microbiol Lett ; 194(2): 245-9, 2001 Jan 15.
Article in English | MEDLINE | ID: mdl-11164316

ABSTRACT

A two-step strategy involving DEAE-cellulose and POROS PI anion exchange chromatography has been developed for rapid purification of acetolactate decarboxylase (ALD) from Leuconostoc lactis NCW1. This results in 5333-fold purification with a yield of 30%. Purified ALD is a dimer of 49-kDa subunits, has a pH optimum of 6.0, a pI of 4.2 and its activity is independent of metals or branched chain amino acids. At the optimum pH, the K(m) for 2-acetolactate (ALA) was found to be 1.3 mM and the turnover number was 4000 min(-1). N-terminal sequence comparison with other ALDs showed little sequence conservation in this region. Purified ALD does not catalyse direct production of diacetyl from ALA, unlike the crude extract.


Subject(s)
Carboxy-Lyases/isolation & purification , Leuconostoc/enzymology , Anion Exchange Resins , Carboxy-Lyases/chemistry , Carboxy-Lyases/metabolism , Diacetyl/metabolism , Hydrogen-Ion Concentration , Isoelectric Point , Leuconostoc/metabolism , Molecular Weight
SELECTION OF CITATIONS
SEARCH DETAIL
...